ConductScience.org, home

Paper36949880

Optimal Duration of Systemic Corticosteroids in Coronavirus Disease 2019 Treatment: A Systematic Review and Meta-analysis.

Ssentongo P and 6 others. Open Forum Infect Dis, 2023. Cited by 8 papers, by iCite.

Cite this record

ConductScience Library. Optimal Duration of Systemic Corticosteroids in Coronavirus Disease 2019 Treatment: A Systematic Review and Meta-analysis. Papers, record 36949880. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36949880

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Optimal Duration of Systemic Corticosteroids in Coronavirus Disease 2019 Treatment: A Systematic Review and Meta-analysis.
PubMed
Journal
Open Forum Infect Dis
PubMed
Year
2023
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
8
iCite
Relative citation ratio, by iCite
0.76
iCite
Revised in PubMed
2023-03-24
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Ssentongo PPaddy
2Yu NNyein
3Voleti NNavya
4Reddy SSurya
5Ingram DDavid
6Chinchilli VMVernon M
7Paules CICatharine I

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References39

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
132345226Clinical characteristics of patients with 2019 coronavirus disease in a non-Wuhan area of Hubei Province, China: a retrospective study.BMC Infect Dis2020https://conductscience.org/library/papers/32345226PubMed
234824060Dexamethasone in hospitalised COVID-19 patients not on intensive respiratory support.Eur Respir J2022https://conductscience.org/library/papers/34824060PubMed
333339536Corticosteroid therapy in critically ill patients with COVID-19: a multicenter, retrospective study.Crit Care2020https://conductscience.org/library/papers/33339536PubMed
433219551High-dose methylprednisolone in nonintubated patients with severe COVID-19 pneumonia.Eur J Clin Invest2021https://conductscience.org/library/papers/33219551PubMed
532817707Tocilizumab and steroid treatment in patients with COVID-19 pneumonia.PLoS One2020https://conductscience.org/library/papers/32817707PubMed
610877304Trim and fill: A simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis.Biometrics2000https://conductscience.org/library/papers/10877304PubMed
725413154PICO, PICOS and SPIDER: a comparison study of specificity and sensitivity in three search tools for qualitative systematic reviews.BMC Health Serv Res2014https://conductscience.org/library/papers/25413154PubMed
832767349Corticosteroid therapy for patients with severe novel Coronavirus disease 2019.Eur Rev Med Pharmacol Sci2020https://conductscience.org/library/papers/32767349PubMed
934396514Systemic corticosteroids for the treatment of COVID-19.Cochrane Database Syst Rev2021https://conductscience.org/library/papers/34396514PubMed
1032634602Corticosteroid therapy for patients with COVID-19 pneumonia: a before-after study.Int J Antimicrob Agents2020https://conductscience.org/library/papers/32634602PubMed
1133534047Methylprednisolone in adults hospitalized with COVID-19 pneumonia : An open-label randomized trial (GLUCOCOVID).Wien Klin Wochenschr2021https://conductscience.org/library/papers/33534047PubMed
1232678530Dexamethasone in Hospitalized Patients with Covid-19.N Engl J Med2021https://conductscience.org/library/papers/32678530PubMed
1326633262Corticosteroids for treating sepsis.Cochrane Database Syst Rev2015https://conductscience.org/library/papers/26633262PubMed
1432971254Efficacy of corticosteroid treatment for hospitalized patients with severe COVID-19: a multicentre study.Clin Microbiol Infect2021https://conductscience.org/library/papers/32971254PubMed
1516807131Random-effects model for meta-analysis of clinical trials: an update.Contemp Clin Trials2007https://conductscience.org/library/papers/16807131PubMed
1632109013Clinical Characteristics of Coronavirus Disease 2019 in China.N Engl J Med2020https://conductscience.org/library/papers/32109013PubMed
1733782057The PRISMA 2020 statement: an updated guideline for reporting systematic reviews.BMJ2021https://conductscience.org/library/papers/33782057PubMed
1833365358Role of Low-Molecular-Weight Heparin in Hospitalized Patients With Severe Acute Respiratory Syndrome Coronavirus 2 Pneumonia: A Prospective Observational Study.Open Forum Infect Dis2020https://conductscience.org/library/papers/33365358PubMed
1932772069Clinical Outcomes Associated With Methylprednisolone in Mechanically Ventilated Patients With COVID-19.Clin Infect Dis2021https://conductscience.org/library/papers/32772069PubMed
2032171076Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study.Lancet2020https://conductscience.org/library/papers/32171076PubMed

See all 39 referencesDownload CSV of references

Cited by7

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 8 citations.

PMIDTitleJournalYearIn PapersSource
41805702Glucocorticoids suppress early lung inflammation and impair control of SARS-CoV-2 in non-human primates.PLoS One2026https://conductscience.org/library/papers/41805702PubMed
41782074The role of corticosteroids in severe viral pneumonia: lessons from COVID-19 and influenza.Pneumonia (Nathan)2026https://conductscience.org/library/papers/41782074PubMed
40425192Association of Extended Steroid Treatment With Bloodstream Infection in Critically Ill Patients With COVID-19: A National, Multicenter, Propensity Score-Matched Study.J Korean Med Sci2025https://conductscience.org/library/papers/40425192PubMed
40340604The clinical impact of prolonged steroid therapy in severe COVID-19 patients: a retrospective cohort study with propensity score matching.BMC Pulm Med2025https://conductscience.org/library/papers/40340604PubMed
40005350Should the Start of Immunosuppressive Treatment for COVID-19 Rely upon the Degree of Inflammation or the Time from Onset?Medicina (Kaunas)2025https://conductscience.org/library/papers/40005350PubMed
39186112Clinical phenotyping uncovers heterogeneous associations between corticosteroid treatment and survival in critically ill COVID-19 patients.Intensive Care Med2024https://conductscience.org/library/papers/39186112PubMed
37892134Insights into COVID-19: Perspectives on Drug Remedies and Host Cell Responses.Biomolecules2023https://conductscience.org/library/papers/37892134PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/36949880

GET https://conductscience.org/api/papers/v1/36949880/references?page=2